Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.
A grade PMID 42321916
View analysis →A grade PMID 42690647
View analysis →A grade PMID 42372741
View analysis →A grade PMID 42216567
View analysis →A grade PMID 41916649
View analysis →A grade PMID 42382416
View analysis →A grade PMID 42150584
View analysis →B grade PMID 42748428
View analysis →A grade PMID 41756844
View analysis →A grade PMID 42765973
View analysis →A grade PMID 42362103
View analysis →A grade PMID 42101908
View analysis →A national benchmark involving 12 radiation oncologists found substantial heterogeneity in postoperative Ewing sarcoma target delineation, with modest improvement but persistent variability after an educational workshop among eight pre/post participants.
The study provides evidence that a delineation workshop can modestly improve selected contour-agreement measures; it is reasonable but unproven to infer that prospective individual case review and radiotherapy quality assurance could improve target coverage, reduce inappropriate irradiation, and ultimately improve clinical outcomes.
In a longitudinal observational study of 218 parents in pediatric oncology, pathogenic or likely pathogenic germline results were associated with greater distress and positive feelings than negative results, while certainty and self-efficacy increased between two post-disclosure assessments.
The evidence identifies result-dependent and evolving parental psychosocial responses but does not test an intervention; it supports the hypothesis that structured, longitudinal communication and psychosocial follow-up tailored to germline result type could reduce distress or improve family adaptation, which requires prospective interventional testing.
This single-centre retrospective study characterized 96 Reserve-antibiotic treatment episodes in 76 pediatric patients—most with hematological malignancies—and describes implementation of formulary restrictions, indication-based electronic prescribing tools, and WHO AWaRe integration.
The record shows that Reserve-antibiotic prescribing patterns were used to design and implement a structured stewardship framework; it is reasonable but unproven to hypothesize that this framework could improve appropriate last-resort antibiotic selection and preserve treatment options for high-risk pediatric oncology patients, because clinical outcomes, resistance effects, safety, and pre/post-implementation impact were not reported.
This narrative review of 17 Japanese studies reports that local-government-led, school-based H. pylori screening and eradication programs for adolescents are feasible, with a median infection prevalence of 3.1%, heterogeneous treatment outcomes, and generally mild reported adverse events.
The reviewed studies support the feasibility of identifying and treating H. pylori infection during adolescence; it is plausible—but not demonstrated by this review—that effective early eradication could reduce subsequent gastric cancer risk, and this requires long-term comparative outcome data.
The study identifies DUSP9 from metastatic versus non-metastatic hepatoblastoma expression data and reports that DUSP9 knockdown reduces hepatoblastoma-cell proliferation, migration, EMT-associated changes, and MAPK-pathway phosphorylation.
The supplied evidence supports DUSP9 as a preclinical regulator and candidate biomarker in hepatoblastoma; it may be inferred that inhibiting DUSP9 could suppress tumor progression through altered MAPK signaling, but no therapeutic agent, safety evidence, or clinical benefit is demonstrated.
In a retrospective two-center cohort of 74 children undergoing distal pancreatectomy or enucleation for benign or low-grade malignant pancreatic tumors, robotic and open surgery had similar complication rates, operative times, and hospital stays, while lower unadjusted blood loss with robotics was not confirmed after multivariable adjustment.
The evidence suggests that robotic non-reconstructive pancreatic surgery may provide perioperative outcomes comparable to open surgery in selected pediatric patients; whether it meaningfully reduces blood loss, toxicity, or recovery burden remains an inference requiring larger prospective or carefully controlled studies.
Across two annual residential retreats attended by 15 and 13 adolescent and young adult childhood-cancer survivors, respectively, participants reported improvements in meaning/purpose and social and emotional self-efficacy, perceived benefits for loneliness, but no change in post-traumatic growth.
The record provides preliminary evidence that repeated community-based retreats may improve selected psychosocial outcomes in underserved minority childhood-cancer survivors; it is an inference, not established here, that fostering connection, reflection, and resilience mediates these benefits or produces durable quality-of-life improvement.
In a retrospective single-center pilot of 30 children with neuroblastoma, multiparametric MRI radiomics achieved preliminary risk-group discrimination, with the best T2-weighted and combined-sequence XGBoost models each reporting an AUC of 0.88.
The study provides preliminary evidence that pretreatment MRI radiomics can classify established neuroblastoma risk groups; it remains an inference, requiring external prospective validation, that such models could complement tissue and molecular testing to support treatment selection or reduce reliance on invasive assessment.
In a retrospective cohort of 44 children undergoing robotic resection of neuroblastic tumors, complete resection was reported in all patients, conversion occurred in 22.7%, two early grade IIIb complications occurred, and higher IDRF score was associated with conversion.
The study provides preliminary clinical evidence that IDRF score is associated with conversion during robotic resection; it is reasonable—but not established—to hypothesize that prospective IDRF-based selection could improve surgical planning and reduce conversion or residual-tumor risk in appropriately selected children.
In a prospective cohort of 45 children with posterior fossa tumors, serial assessments showed marked deterioration in swallowing and chewing one week after surgery with incomplete recovery at four weeks, particularly among children with ependymoma or medulloblastoma and those undergoing partial resection.
The study provides evidence that early postoperative dysphagia trajectories vary by tumor histology and extent of resection; it is reasonable but untested to hypothesize that risk-stratified screening and earlier individualized swallowing rehabilitation could improve functional recovery or reduce dysphagia-related complications.
In a single-center retrospective cohort of 93 immunocompromised patients aged 0–26 years receiving high-flow nasal cannula, higher FLOX values—particularly FLOX ≥0.20—were associated with greater odds of subsequent intubation.
The study provides evidence that FLOX is associated with HFNC failure in this cohort; it remains an inference, requiring prospective external validation, that serial FLOX assessment could support earlier escalation decisions and thereby improve outcomes in immunocompromised pediatric oncology patients.
In a retrospective cohort of 31 patients with pontine gliomas or cerebellar metastases, larger tumor volume, proximity to the fourth ventricle, and distorted ventricular configuration were associated with hydrocephalus, whereas radiotherapy dose was not.
The reported imaging features could, if independently validated, support earlier hydrocephalus surveillance or intervention planning in patients with posterior fossa tumors; however, the study provides risk associations rather than evidence that imaging-guided management improves outcomes.
